| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 9,275,431 | 10,319,386 | 7,583,888 | | Cost of Revenue | 1,066,245 | 979,643 | 820,344 | | | Gross Profit | 8,209,186 | 9,339,743 | 6,763,544 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,830,425 | 5,681,116 | 4,282,777 | | Non Recurring | 282,314 | 499,506 | 14,588 | | Others | 1,440,208 | 1,634,098 | 1,359,230 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,656,239 | 1,525,022 | 1,106,949 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (94,105) | 232,423 | 144,161 | | Earnings Before Interest And Taxes | 1,562,135 | 1,757,446 | 1,251,110 | | Interest Expense | 470,523 | 627,950 | 533,738 | | Income Before Tax | 1,091,612 | 1,129,495 | 717,372 | | Income Tax Expense | 273,312 | 126,406 | 48,054 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 818,300 | 1,003,090 | 669,318 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 818,300 | 1,003,090 | 669,318 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $818,300 | $1,003,090 | $669,318 |
|
0.29% Nasdaq 
Income Statement
